Verastem (VSTM) Net Income (2011 - 2026)
Verastem (VSTM) posted quarterly Net Income of -$44.5 million for Q1 2026, little changed year-over-year from -$44.5 million in Q1 2025, and down 1487.92% quarter-over-quarter from $3.2 million in Q4 2025.
Analysis
Verastem (VSTM) Net Income (2011 - 2026) Analysis & Trends
Verastem's Net Income history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.
- In Q1 2026, Net Income changed 0.11% year-over-year to -$44.5 million; the TTM figure through Mar 2026 stood at -$139.5 million (down 5.54% YoY), while the FY2025 annual figure was -$165.5 million, down 26.66% from the prior year.
- Net Income for Q1 2026 stood at -$44.5 million, down from $3.2 million in the prior quarter.
- The five-year high for Net Income was $3.2 million in Q4 2025, with the low at -$54.0 million in Q2 2025.
- The 5-year median for Net Income is -$22.0 million (2022), against an average of -$27.5 million.
- Peak annual rise in Net Income reached 110.02% in 2025, while the deepest fall reached 192.7% in 2025.
- Verastem's Net Income stood at -$16.8 million in 2022, then slumped by 80.88% to -$30.4 million in 2023, then fell by 5.19% to -$32.0 million in 2024, then surged by 110.02% to $3.2 million in 2025, then plunged by 1487.92% to -$44.5 million in 2026.
- Business Quant data shows VSTM's Net Income at -$44.5 million in Q1 2026, $3.2 million in Q4 2025, and -$44.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 601.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Verastem | 815.95 Mn | 679.59 Mn | 36.32 Mn | -34.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.67 Mn |
| Mar 31, 2026 | -43.98 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | -39.85 Mn |
| Jun 30, 2025 | -25.93 Mn |
| Mar 31, 2025 | -43.41 Mn |
| Dec 31, 2024 | -31.97 Mn |
| Sep 30, 2024 | -37.35 Mn |
| Jun 30, 2024 | -18.43 Mn |
| Mar 31, 2024 | -27.82 Mn |
| Dec 31, 2023 | -30.39 Mn |
| Sep 30, 2023 | -20.19 Mn |
| Jun 30, 2023 | -20.29 Mn |
| Mar 31, 2023 | -19.14 Mn |
| Dec 31, 2022 | -16.80 Mn |
| Sep 30, 2022 | -18.11 Mn |
| Jun 30, 2022 | -21.96 Mn |
| Mar 31, 2022 | -16.99 Mn |
| Dec 31, 2021 | -16.48 Mn |
| Sep 30, 2021 | -22.79 Mn |